BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30216231)

  • 1. Measuring Community Prevalence of Trichomonas vaginalis Infection to Guide Local Screening Practices: A Process Improvement Project.
    Weger BO; Klein DA; Bowsher BL; Weir LF; Roberts TA
    Sex Transm Dis; 2019 Feb; 46(2):e11-e13. PubMed ID: 30216231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for
    Mabaso N; Naicker C; Nyirenda M; Abbai N
    Int J STD AIDS; 2020 Mar; 31(4):351-358. PubMed ID: 32075536
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay.
    Freeman AH; Katz KA; Pandori MW; Rauch LM; Kohn RP; Liska S; Bernstein KT; Klausner JD
    Sex Transm Dis; 2010 Mar; 37(3):165-8. PubMed ID: 20023598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichomonas vaginalis infections are rare among young patients attending an STI clinic in Sweden.
    Pellrud H; Golparian D; Nilsson CS; Falk M; Fredlund H; Unemo M
    Acta Derm Venereol; 2015 Mar; 95(3):343-4. PubMed ID: 25137630
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of Trichomonas vaginalis Among Civilian, Noninstitutionalized Male and Female Population Aged 14 to 59 Years: United States, 2013 to 2016.
    Flagg EW; Meites E; Phillips C; Papp J; Torrone EA
    Sex Transm Dis; 2019 Oct; 46(10):e93-e96. PubMed ID: 31517807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Offering routine trichomonas vaginalis testing to patients presenting for abortion at an urban hospital-based clinic.
    Cheeks ML; Schwartz R; Oleson EC; Cohen S; Drey EA; Seidman D
    Contraception; 2021 Jun; 103(6):423-425. PubMed ID: 33539801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
    Van der Pol B
    Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
    [No Abstract]   [Full Text] [Related]  

  • 9. Aptima
    Bruni MP; Freitas da Silveira M; Stauffert D; Bicca GLO; Caetano Dos Santos C; da Rosa Farias NA; Golparian D; Unemo M
    Sex Transm Infect; 2019 Mar; 95(2):129-132. PubMed ID: 30154157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichomonas vaginalis in Turkey--a review.
    Saygi G
    Wiad Parazytol; 2001; 47 Suppl 1():3-7. PubMed ID: 16897944
    [No Abstract]   [Full Text] [Related]  

  • 11. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with Trichomonas vaginalis infection in reproductive-aged women attending cervical screening in southeast of Brazil.
    da Silva Pinto GV; Bolpet ADN; Martin LF; Moço NP; Ramos BRA; Silva MC; Duarte MTC; da Rocha Tristão A; da Silva MG; Marconi C
    Braz J Infect Dis; 2023; 27(4):102794. PubMed ID: 37500061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
    Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
    Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of Trichomonas vaginalis in liquid-based Papanicolaou samples in Shiraz, southern Iran.
    Bahreini MS; Sedghi S; Badalzadeh Y; Motazedian MH; Shirani M; Jahromi SS; Teimouri A; Agholi M; Asgari Q
    BMC Womens Health; 2023 Jan; 23(1):6. PubMed ID: 36604666
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Field N; Clifton S; Alexander S; Ison CA; Khanom R; Saunders P; Hughes G; Heath L; Beddows S; Mercer CH; Tanton C; Johnson AM; Sonnenberg P
    Sex Transm Infect; 2018 May; 94(3):226-229. PubMed ID: 27686884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates.
    Sutcliffe S; Newman SB; Hardick A; Gaydos CA
    Sex Transm Dis; 2010 Sep; 37(9):585-90. PubMed ID: 20803782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis.
    Fouts AC; Kraus SJ
    J Infect Dis; 1980 Feb; 141(2):137-143. PubMed ID: 6965976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
    Roth AM; Williams JA; Ly R; Curd K; Brooks D; Arno J; Van Der Pol B
    Sex Transm Dis; 2011 May; 38(5):398-400. PubMed ID: 21217417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichomoniasis and retesting in Durham County, North Carolina, United States, 2021 - 2022.
    Jenks JD; Ryan E; Stancil C; Harris K; Hester L; Carrico S; Mortiboy M; Zitta JP
    Int J STD AIDS; 2024 May; 35(6):412-417. PubMed ID: 38225875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.